Media
The latest news, announcements and media resources
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo and video library.
Key information
2018 Full year and fourth quarter results announcement
We announced our full year and fourth quarter results for the period ended 31 December 2018 on Wednesday 06 February.
Latest press releases
- GSK announces further positive data from DREAMM-1 study of anti-BCMA antibody-drug conjugate in patients with relapsed/refractory multiple myeloma
- Data from GARNET study indicates robust activity of dostarlimab in patients with advanced or recurrent endometrial cancer
- ViiV Healthcare presents positive, 48-week data from two pivotal phase III studies showing long-acting, injectable two-drug regimen of cabotegravir and rilpivirine has similar efficacy to daily, three-drug oral treatment in adults living with HIV-1 infection
- GSK receives a positive CHMP opinion for intravenous zanamivir for the treatment of complicated influenza
GSK Twitter
-
GSK @GSK
We are proud to be one of 60+ companies, with @StopTB, committed to advancing #TBinnovation and to #endTB. Read the statement by the Private Sector Constituency on #WorldTBDay: gsk.to/2HG3vKm #ItsTimetoEndTB
about 5 hours ago -
GSK @GSK
TB claimed 1.6 million lives in 2017, according to @WHO. Watch to find out how our scientists are working with others to help fight one of the world’s biggest killers #WorldTBDay
about 1 day ago
GSK and Pfizer to form new world-leading Consumer Healthcare Joint Venture
On 19 December 2018 we announced our agreement with Pfizer to combine our consumer health businesses into a new world-leading Joint Venture. Watch Emma Walmsley discuss the proposed transaction and how we’re accelerating our strategy.